Novel strategies in diastolic heart failure.
Paulus
Walter J
WJ
Department of Physiology, VU University Medical Center Amsterdam, Van der Boechorststraat 7 1081 BT, Amsterdam, The Netherlands. wj.paulus@vumc.nl
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D054144:Heart Failure, Diastolic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000209:etiology
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors